• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 12-11-2025: Board Meeting

    12-11-2025 | 03:38 pm

    Venmax Drugs' board approved Q2 & H1 financial results. The company posted ₹1.32 Cr revenue for Q2 and ₹2.53 Cr for H1, with H1 net profit at ₹0.06 Cr. Additionally, the board furthered the Hatri Pharma merger, approving financials for valuation. #VenmaxDrugs #Q2FY26

    No comments yet. Be the first to comment!

    All announcements from Venmax Drugs and Pharmaceuticals Ltd